Last $1.59 HKD
Change Today +0.03 / 1.92%
Volume 720.0K
512 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 11:00 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

china grand pharmaceutical a (512) Snapshot

Open
$1.57
Previous Close
$1.56
Day High
$1.59
Day Low
$1.57
52 Week High
04/15/14 - $1.82
52 Week Low
09/9/13 - $0.57
Market Cap
3.1B
Average Volume 10 Days
1.8M
EPS TTM
$0.05
Shares Outstanding
2.0B
EX-Date
05/20/97
P/E TM
31.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA GRAND PHARMACEUTICAL A (512)

Related News

No related news articles were found.

china grand pharmaceutical a (512) Related Businessweek News

No Related Businessweek News Found

china grand pharmaceutical a (512) Details

China Grand Pharmaceutical and Healthcare Holdings Limited, an investment holding company, develops, manufactures, and sells pharmaceutical preparations, pharmaceutical intermediates, specialized pharmaceutical raw materials, and healthcare products. The company offers pharmaceutical preparations, such as cerebro-cardiovascular, ophthalmic gel and eye drops, antibacterial, antibiotics, and antipyretics and analgesic products; and active pharmaceutical ingredients (APIs), which include analgin, metronidazole and chloramphenicol, and other amino acids. It also provides steroid hormones APIs and its intermediates, including glucocorticoid and sex hormones, as well as prednisone series. In addition, the company offers Taurine, an organic amino acid that is used to enhance immunity system and increase level of cell differentiation, growth, and supplement in infant milk powder, as well as used in energy drinks and in treatment of various heart diseases. Further, it provides agricultural chemicals comprising bio-pesticides, biocides, and bio-feed additives; and fine chemicals, such as calcium superphosphate and dimethyl sulfate. China Grand Pharmaceutical and Healthcare Holdings Limited has operations primarily in the People’s Republic of China, as well as in the United States, Europe, Asia, and internationally. The company was incorporated in 1995 and is based in Central, Hong Kong. China Grand Pharmaceutical and Healthcare Holdings Limited is a subsidiary of Outwit Investments Limited.

5,400 Employees
Last Reported Date: 04/28/14
Founded in 1995

china grand pharmaceutical a (512) Top Compensated Officers

Chief Executive Officer, Executive Director a...
Total Annual Compensation: $1.5M
Compensation as of Fiscal Year 2013.

china grand pharmaceutical a (512) Key Developments

China Grand Pharmaceutical and Healthcare Holdings Ltd. Presents at Hong Kong and China Corporate Day (Theme: Healthcare) 2014, Jul-08-2014

China Grand Pharmaceutical and Healthcare Holdings Ltd. Presents at Hong Kong and China Corporate Day (Theme: Healthcare) 2014, Jul-08-2014 . Venue: Island Shangri-la Hotel, Hong Kong.

China Grand Pharmaceutical and Healthcare Holdings Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2013

China Grand Pharmaceutical and Healthcare Holdings Ltd. announced audited consolidated earnings results for the year ended December 31, 2013. For the period, the company reported turnover of HKD 2,658,282,000 compared to HKD 2,059,307,000 a year ago. Profit before tax was HKD 132,280,000 compared to HKD 115,535,000 a year ago. Profit for the year attributable to owners of the company was HKD 99,658,000 or 5.08 cents per basic and diluted share compared to HKD 67,305,000 or 3.46 cents per basic and diluted share a year ago.

China Grand Pharmaceutical and Healthcare Holdings Ltd., Annual General Meeting, May 30, 2014

China Grand Pharmaceutical and Healthcare Holdings Ltd., Annual General Meeting, May 30, 2014., at 11:00 China Standard Time. Location: Unit 3302, The Centre. Agenda: To adopt the audited financial statements together with the report of the directors and the report of the auditors for the year ended 31 December 2013; to re-elect retiring directors and to authorize the board of directors to fix their remuneration; to re-appoint HLB Hodgson Impey Cheng Limited as auditors to hold office until the conclusion of the next annual general meeting and to authorize the directors to fix their remuneration; and to consider all the powers of the directors to allot and issue additional shares.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
512:HK $1.59 HKD +0.03

512 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY52.45 CNY -2.02
View Industry Companies
 

Industry Analysis

512

Industry Average

Valuation 512 Industry Range
Price/Earnings 30.7x
Price/Sales 1.2x
Price/Book 3.5x
Price/Cash Flow 30.7x
TEV/Sales 0.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA GRAND PHARMACEUTICAL A, please visit www.chinagrandpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.